Treatment of cockroach allergen asthma model with imatinib attenuates airway responses (Q45063930)

9 December 2017

Treatment of cockroach allergen asthma model with imatinib attenuates airway responses (English)

1 reference

9 December 2017

0 references

1 reference

Aaron A Berlin

1

1 reference

PubMed ID

15374841

9 December 2017

Nicholas W Lukacs

series ordinal

2

1 reference

PubMed ID

15374841

9 December 2017

language of work or name

English

0 references

publication date

16 September 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

9 December 2017

1 reference

9 December 2017

171

1 reference

9 December 2017

1

1 reference

9 December 2017

35-39

1 reference

Pathophysiology of severe asthma

9 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Epidemiology of asthma: the year in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Is asthma really due to a polarized T cell response toward a helper T cell type 2 phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Endogenous inhibitory mechanisms in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Efficacy and safety of inhaled corticosteroids. New developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Eosinophil granule proteins and their role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Mechanisms of eosinophil-associated inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Role of chemokines in asthmatic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Airway hyperresponsiveness: first eosinophils and then neuropeptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Cellular and molecular mechanisms involved in the regulation of eosinophil trafficking in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Airway eosinophils, T cells, Th2-type cytokine mRNA, and hyperreactivity in response to aerosol challenge of allergic mice with previously established pulmonary inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Molecular monitoring of chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

STI571 as a targeted therapy for CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Imatinib: the first 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Imatinib: a selective tyrosine kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Recombinant stem cell factor-induced mast cell activation and smooth muscle contraction in human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Stem cell factor-induced airway hyperreactivity in allergic and normal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Stem cell factor: a hemopoietic cytokine with important targets in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

The expression of stem cell factor and c-kit receptor in human asthmatic airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Airmax: a multi-dose dry powder inhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Tyrosine kinase inhibitors: from rational design to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Effective treatment of hypereosinophilic syndrome with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Efficacy of imatinib mesylate in the treatment of idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

The rat c-kit ligand, stem cell factor, induces c-kit receptor-dependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit receptor can induce expression of cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Increased IFN-gamma synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Chronic myelogenous leukemia in T cell lymphoid blastic phase achieving durable complete cytogenetic and molecular remission with imatinib mesylate (STI571; Gleevec) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200403-385OC

10.1164/RCCM.200403-385OC

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

15374841